Lucknow: Heart patients in UP will soon be able to receive timely treatment at their nearest district hospital or community ...

The findings hint at why the ABYSS trial failed to show it was safe to stop beta-blockers after an MI in stable patients.

Predicting Risk of Cardiovascular Disease Events (PREVENT) risk score accurately identifies individuals with coronary artery calcium.

Silent heart attacks often occur without noticeable symptoms. Unusual fatigue is a key early warning sign. Other subtle signs ...

Regional ST-segment–elevation myocardial infarction systems are being developed to improve timely access to primary percutaneous coronary intervention (PCI). System delays may diminish the mortality ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 26, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

Women with breast implants may experience abnormal cardiac test results and complications, emphasizing the need for awareness ...

The following is a summary of “Apelinergic System in the Left Ventricle Adverse Remodeling After Myocardial Infarction: A ...

Presented at EuroPCR 2025, the 10-year results of the DANAMI-3-PRIMULTI trial show how complete revascularisation cuts ...

Department of Chemistry, International Institute for Nanotechnology, Simpson-Querrey Institute, Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois 60208, United States ...

Although the 400-person study was too small to really compare clinical outcomes, Tanigaki said a count of major adverse ...

Elixir Medical announced three-year results from a large randomized controlled trial of its DynamX coronary bioadaptor system.